|
[1]
|
Müller, J., Wallukat, G., Dandel, M., et al. (2000) Immunoglobulin Adsorption in Patients with Idiopathic Dilated Car-diomyopathy. Circulation, 101, 385-391. [Google Scholar] [CrossRef]
|
|
[2]
|
Nussinovitch, U. and Shoenfeld, Y. (2008) Intravenous Immunoglobulin—Indications and Mechanisms in Cardiovascular Diseases. Autoim-munity Reviews, 7, 445-452. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
贾建军, 庞永峰. 住院患者扩张型心肌病临床流行病学调查分析[J]. 医学信息, 2017, 30(9): 36-38. [Google Scholar] [CrossRef]
|
|
[4]
|
廖玉华. 中国扩张型心肌病诊断和治疗指南:创新与转化[J]. 临床心血管病杂志, 2018, 34(5): 435-436. [Google Scholar] [CrossRef]
|
|
[5]
|
Nussinovitch, U. and Shoenfeld, Y. (2013) The Clin-ical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease. Clinical Reviews in Allergy & Immunology, 44, 75-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Brustovetsky, N. (2020) The Role of Adenine Nucleotide Trans-locase in the Mitochondrial Permeability Transition. Cells, 9, Article 2686. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Dörner, A. and Schultheiss, H.P. (2007) Adenine Nucleotide Trans-locase in the Focus of Cardiovascular Diseases. Trends in Cardiovascular Medicine, 17, 284-290. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Schulze, K., Becker, B.F., Schauer, R., et al. (1990) Antibodies to ADP-ATP Carrier—An Autoantigen in Myocarditis and Dilated Cardiomyopathy—Impair Cardiac Function. Circulation, 81, 959-969. [Google Scholar] [CrossRef]
|
|
[9]
|
Schultheiss, H.P. and Bolte, H.D. (1985) Immunological Analysis of Auto-Antibodies against the Adenine Nucleotide Translocator in Dilated Cardiomyopathy. Journal of Molecular and Cellular Cardiology, 17, 603-617. [Google Scholar] [CrossRef]
|
|
[10]
|
张百会. 抗ANT抗体阳性与扩张型心肌病临床预后的关系[D]: [硕士学位论文]. 呼和浩特: 内蒙古医科大学, 2017.
|
|
[11]
|
Tsuneyama, K., Baba, H., Morimoto, Y., et al. (2017) Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms. The Journal of Medical Investigation, 64, 7-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Berg, P.A. and Klein, R. (1986) Mitochon-drial Antigens and Autoantibodies: From Anti-M1 to Anti-M9. Klinische Wochenschrift, 64, 897-909. [Google Scholar] [CrossRef]
|
|
[13]
|
Klein, R., Maisch, B., Kochsiek, K., et al. (1984) Demonstration of Or-gan Specific Antibodies against Heart Mitochondria (Anti-M7) in Sera from Patients with Some Forms of Heart Diseases. Clinical and Experimental Immunology, 58, 283-292.
|
|
[14]
|
Otto, A., Stähle, I., Klein, R., et al. (1998) An-ti-Mitochondrial Antibodies in Patients with Dilated Cardiomyopathy (Anti-M7) Are Directed against Flavoenzymes with Covalently Bound FAD. Clinical and Experimental Immunology, 111, 541-547. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Saito, T., Kodani, E., Katayama, H., et al. (2018) Eosino-philic Myocarditis Associated with Anti-Mitochondrial M2 Antibodies: A Mechanism Underlying the Onset of Myocar-ditis. European Heart Journal, 39, 3480-3481. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Yokokawa, T., Yoshihisa, A., Misaka, T., et al. (2021) An-ti-Mitochondrial Antibodies in Patients with Dilated Cardiomyopathy. Internal Medicine, 60, 201-208. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Konishi, H., Fukuzawa, K., Mori, S., et al. (2017) An-ti-Mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobili-ary Enzyme Levels. Internal Medicine, 56, 1771-1779. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Nikolaev, V.O., Boivin, V., Störk, S., et al. (2007) A Novel Fluorescence Method for the Rapid Detection of Functional Beta1-Adrenergic Receptor Autoantibodies in Heart Failure. Journal of the American College of Cardiology, 50, 423-431. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Matsui, S., Fu, M.L., Shimizu, M., et al. (1995) Dilated Cardiomy-opathy Defines Serum Autoantibodies against G- Protein-Coupled Cardiovascular Receptors. Autoimmunity, 21, 85-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wallukat, G., Morwinski, M., Kowal, K., et al. (1991) Autoan-tibodies against the Beta-Adrenergic Receptor in Human Myocarditis and Dilated Cardiomyopathy: Beta-Adrenergic Agonism without Desensitization. European Heart Journal, 12, 178-181. [Google Scholar] [CrossRef]
|
|
[21]
|
Wallukat, G., Wollenberger, A., Morwinski, R., et al. (1995) Anti-Beta 1-Adrenoceptor Autoantibodies with Chronotropic Activity from the Serum of Patients with Dilated Cardio-myopathy: Mapping of Epitopes in the First and Second Extracellular Loops. Journal of Molecular and Cellular Cardi-ology, 27, 397-406. [Google Scholar] [CrossRef]
|
|
[22]
|
Wess, G., Wallukat, G., Fritscher, A., et al. (2019) Dober-man Pinschers Present Autoimmunity Associated with Functional Autoantibodies: A Model to Study the Autoimmune Background of Human Dilated Cardiomyopathy. PLOS ONE, 14, e0214263. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Liu, J., Wang, Y., Chen, M., et al. (2014) The Correlation be-tween Peripartum Cardiomyopathy and Autoantibodies against Cardiovascular Receptors. PLOS ONE, 9, e86770. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Camino, M. and Morales, M.D. (2019) Beta1-Adrenergic Re-ceptor Antibodies in Children with Dilated Cardiomyopathy. Frontiers in Bioscience-Elite, 11, 102-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
房慧娟, 韩波, 朱梅, 等. 扩张型心肌病患儿外周血抗β1肾上腺素能受体抗体与结缔组织生长因子表达的意义[J]. 中华实用儿科临床杂志, 2017, 32(1): 30-33. [Google Scholar] [CrossRef]
|
|
[26]
|
Stavrakis, S., Kem, D.C., Patterson, E., et al. (2011) Opposing Cardiac Effects of Autoantibody Activation of β-Adre- nergic and M2 Muscarinic Receptors in Cardi-ac-Related Diseases. International Journal of Cardiology, 148, 331-336. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Fu, L.X., Magnusson, Y., Bergh, C.H., et al. (1993) Localization of a Functional Autoimmune Epitope on the Muscarinic Acetylcholine Receptor-2 in Patients with Idiopathic Dilated Car-diomyopathy. The Journal of Clinical Investigation, 91, 1964-1968. [Google Scholar] [CrossRef]
|
|
[28]
|
Nascimento, J.H., Sallé, L., Hoebeke, J., et al. (2001) cGMP-Mediated In-hibition of Cardiac L-Type Ca(2+) Current by a Monoclonal Antibody against the M2 ACh Receptor. American Journal of Physiology, 281, C1251-C1258. [Google Scholar] [CrossRef]
|
|
[29]
|
Zhang, S., He, Z., Wang, J., et al. (2015) Mitochondrial Ul-trastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic Receptor. PLOS ONE, 10, e0129563. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
刘蓉, 乔树宾, 胡奉环, 等. 心脏β_1肾上腺素能受体和M_2乙酰胆碱能受体的自身抗体与肥厚型心肌病的关系研究[J]. 中国循环杂志, 2017, 32(11): 1104-1106.
|
|
[31]
|
Caforio, A.L., Grazzini, M., Mann, J.M., et al. (1992) Identification of Alpha- and Beta-Cardiac Myo-sin Heavy Chain Isoforms as Major Autoantigens in Dilated Cardiomyopathy. Circulation, 85, 1734-1742. [Google Scholar] [CrossRef]
|
|
[32]
|
Ansari, A.A., Neckelmann, N., Wang, Y.C., et al. (1993) Immuno-logic Dialogue between Cardiac Myocytes, Endothelial Cells, and Mononuclear Cells. Clinical Immunology and Im-munopathology, 68, 208-214. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
汪朝晖, 廖玉华, 董继华, 等. 肌球蛋白致自身免疫性心肌疾病的实验研究[J]. 中华心血管病杂志, 2003(12): 60-63.
|
|
[34]
|
朱筱娟, 茂昆, 赵建增, 等. 肌球蛋白单克隆抗体标记大鼠心肌坏死的研究[J]. 动物学报, 2001, 47(3): 351-354. [Google Scholar] [CrossRef]
|
|
[35]
|
王秋芬, 廖玉华, 龚非力, 等. 扩张型心肌病抗心肌肌球蛋白抗体与Th细胞亚群分析[J]. 中国免疫学杂志, 2003(1): 64-65.
|
|
[36]
|
Kühl, U., Melzner, B., Schäfer, B., et al. (1991) The Ca-Channel as Cardiac Autoantigen. European Heart Journal, 12, 99-104. [Google Scholar] [CrossRef]
|
|
[37]
|
涂丹娜, 廖玉华, 田苗, 等. 抗大鼠心室肌细胞L-型钙通道亚单位抗体的制备与验证[J]. 中国免疫学杂志, 2005(10): 724-727.
|
|
[38]
|
肖华, 廖玉华, 王敏, 等. 扩张型心肌病新型抗钙通道抗体的发现[J]. 临床心血管病杂志, 2007(8): 601-605.
|
|
[39]
|
滑劲咏, 曹巍, 卢迎宏, 等. 抗心肌抗体联合C反应蛋白与扩张型心肌病并发室性心律失常的关系研究[J]. 中国循证心血管医学杂志, 2020, 12(5): 554-557.
|
|
[40]
|
Gething, M.J. and Sambrook, J. (1992) Protein Folding in the Cell. Nature, 355, 33-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
陈曦. 热休克蛋白及热休克蛋白70家族进化保守性的系统分析[D]: [硕士学位论文]. 大连: 辽宁师范大学, 2011.
|
|
[42]
|
Chen, H.S., Shan, Y.X., Yang, T.L., et al. (2005) Insulin Defi-ciency Downregulated Heat Shock Protein 60 and IGF-1 Receptor Signaling in Diabetic Myocardium. Diabetes, 54, 175-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Chen, W., Syldath, U., Bellmann, K., et al. (1999) Human 60-kDa Heat-Shock Protein: A Danger Signal to the Innate Immune System. The Journal of Immunology, 162, 3212-3219. [Google Scholar] [CrossRef]
|
|
[44]
|
Okazaki, T. and Honjo, T. (2005) Pathogenic Roles of Cardiac Autoantibodies in Dilated Cardiomyopathy. Trends in Molecular Medicine, 11, 322-326. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Tishler, M. and Shoenfeld, Y. (1996) Anti-Heat-Shock Protein Antibodies in Rheumatic and Autoimmune Diseases. Seminars in Arthritis and Rheumatism, 26, 558-563. [Google Scholar] [CrossRef]
|
|
[46]
|
Minota, S., Cameron, B., Welch, W.J., et al. (1988) Autoan-tibodies to the Constitutive 73-kD Member of the HSP70 Family of Heat Shock Proteins in Systemic Lupus Erythema-tosus. Journal of Experimental Medicine, 168, 1475-1480. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Jarjour, W.N., Jeffries, B.D., Davis, J.S.T., et al. (1991) Autoantibod-ies to Human Stress Proteins. A Survey of Various Rheumatic and Other Inflammatory Diseases. Arthritis & Rheuma-tology, 34, 1133-1138. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Abulafia-Lapid, R., Gillis, D., Yosef, O., et al. (2003) T Cells and Autoantibodies to Human HSP70 in Type 1 Diabetes in Children. Journal of Autoimmunity, 20, 313-321. [Google Scholar] [CrossRef]
|
|
[49]
|
Portig, I., Pankuweit, S. and Maisch, B. (1997) Antibodies against Stress Proteins in Sera of Patients with Dilated Cardiomyopathy. Journal of Molecular and Cellular Cardiology, 29, 2245-2251. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Matsumori, A. and Kawai, C. (1982) An Experimental Model for Congestive Heart Failure after Encephalomyocarditis Virus Myocarditis in Mice. Circulation, 65, 1230-1235. [Google Scholar] [CrossRef]
|
|
[51]
|
Weinmann, K., Werner, J., Koenig, W., et al. (2019) Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Car-diomyopathy. Biomolecules, 9, Article 654. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
何芳, 唐婷婷, 谢天. 免疫吸附疗法应用于扩张型心肌病患者的1例病例报告并荟萃分析[J]. 临床心血管病杂志, 2022, 38(3): 233-240. [Google Scholar] [CrossRef]
|
|
[53]
|
Felix, S.B. and Staudt, A. (2008) Immunoadsorption as Treatment Option in Dilated Cardiomyopathy. Autoimmunity, 41, 484-489. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
张默晴, 常贺, 王焱. 心肌炎及扩张型心肌病免疫发病机制的研究进展[J]. 福建医药杂志, 2015, 37(5): 124-126.
|
|
[55]
|
Maisch, B. and Alter, P. (2018) Treatment Options in Myocarditis and Inflammatory Cardiomyopathy: Focus on i. v. Immunoglobulins. Herz, 43, 423-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., et al. (2001) Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyo-pathy: Two-Year Follow-Up Results. Circulation, 104, 39-45. [Google Scholar] [CrossRef]
|
|
[57]
|
Matoba, Y., Okubo, H. and Nosé, Y. (2004) Therapeutic Left Ven-tricular Assist Device and Apheresis on Dilated Cardiomyopathy. Artificial Organs, 28, 171-181. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Nagatomo, Y., Baba, A., Ito, H., et al. (2011) Specific Immunoadsorption Therapy Using a Tryptophan Column in Patients with Refractory Heart Failure Due to Dilated Car-diomyopathy. Journal of Clinical Apheresis, 26, 1-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Moriguchi, T., Koizumi, K., Matsuda, K., et al. (2017) Plasma Exchange for the Patients with Dilated Cardiomyopathy in Children Is Safe and Effective in Improving Both Cardiac Function and Daily Activities. Journal of Artificial Organs, 20, 236-243. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Haberland, A., Holtzhauer, M., Schlichtiger, A., et al. (2016) Ap-tamer BC 007—A Broad Spectrum Neutralizer of Pathogenic Autoantibodies against G-Protein-Coupled Receptors. Eu-ropean Journal of Pharmacology, 789, 37-45. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Werner, S., Wallukat, G., Becker, N.P., et al. (2020) The Ap-tamer BC 007 for Treatment of Dilated Cardiomyopathy: Evaluation in Doberman Pinschers of Efficacy and Outcomes. ESC Heart Failure, 7, 844-855.
|
|
[62]
|
王彬宇, 王妍, 郭冰立, 等. 沙库巴曲缬沙坦治疗缺血性心肌病与扩张型心肌病所致心力衰竭的效果比较[J]. 中国医药, 2022, 17(1): 19-23.
|
|
[63]
|
袁佳君, 张伟. 依那普利联合美托洛尔治疗扩张型心肌病的临床疗效[J]. 临床合理用药杂志, 2021, 14(6): 8-10. [Google Scholar] [CrossRef]
|
|
[64]
|
袁文金, 李文峰, 罗刚, 等. 左西孟旦对扩张型心肌病的作用及机制[J]. 中国老年学杂志, 2019, 39(1): 175-177.
|
|
[65]
|
Briganti, F., Sun, H., Wei, W., et al. (2020) iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy. Cell Reports, 32, Article ID: 108117. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
高晓明, 吕欣. 扩张型心肌病病人心理状况分析及心理干预[J]. 全科护理, 2017, 15(5): 567-568.
|
|
[67]
|
Wittekind, S.G., Gerdes, Y., Mays, W., et al. (2018) Cardiac Rehabilitation Improves Cardiometabolic Health in Young Patients with Nonischemic Dilated Cardiomy-opathy. Texas Heart Institute Journal, 45, 27-30. [Google Scholar] [CrossRef]
|
|
[68]
|
宋丽, 付丹, 田飞, 等. 中西药联合治疗扩张型心肌病疗效的系统评价Meta分析[J]. 中医临床研究, 2021, 13(31): 143-148.
|